| Announce Date | 02/04/2026 |
| EPS Normalized Actual | $-0.03562 (Beat by $0.08438) |
| EPS GAAP Actual | $-0.03562 (Beat by $0.08438) |
| Revenue Actual | $1.15081B |
| Revenue Surprise | Beat by $1150.81M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.33 |
| EPS GAAP Estimate | $0.33 |
| Revenue Estimate | $1.659B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | -0.13 | -62.31 | -0.14242 | -0.12224 | 1 |
| Dec 2027 | 0.58 | 13.97 | 0.55576 | 0.60145 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.024 | -0.3059 | 1.15081B | -0.98% | -487.75M |
| FQ3 2025 (Sep 2025) | -0.0951 | -0.32907 | 1.17595B | -15.41% | -419.73M |
| FQ2 2025 (Jun 2025) | -0.12 | -0.37871 | 1.21932B | -10.57% | -403.03M |
| FQ1 2025 (Mar 2025) | 0.0026 | 0.0026 | 1.28054B | -17.95% | 1280.54M |
| FQ4 2024 (Dec 2024) | -0.13 | -0.13 | 1.16214B | -36.33% | 1162.14M |
| FQ3 2024 (Sep 2024) | -2.45 | -2.45 | 1.35722B | 25.48% | 1357.22M |
| FQ2 2024 (Jun 2024) | 0.0277 | 0.0277 | 1.34819B | 43.71% | 1348.19M |
| FQ1 2024 (Mar 2024) | 0.13 | 0.13 | 1.51036B | 47.58% | 1510.36M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.33
Consensus Revenue Estimates
1.659B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.14 | -- | 0.12979 | 0.14993 | 5 |
| FQ3 2027 (Sep 2027) | 0.17 | -- | 0.1576 | 0.18205 | 2 |
| FQ2 2027 (Jun 2027) | 0.15 | -- | 0.13906 | 0.16064 | 2 |
| FQ1 2027 (Mar 2027) | 0.12 | -- | 0.11125 | 0.12851 | 2 |
| FQ4 2026 (Oct 2026) | 0.36 | 106.67 | 0.33391 | 0.3836 | 5 |
| FQ3 2026 (Jul 2026) | 0.34 | 127.97 | 0.31536 | 0.36229 | 5 |
| FQ2 2026 (Jun 2026) | 0.35 | 134.29 | 0.34463 | 0.36231 | 5 |
| FQ1 2026 (Mar 2026) | 0.33 | 99.21 | 0.32494 | 0.34161 | 11 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.39B | -- | 1.32B | 1.47B | 5 |
| FQ3 2027 (Sep 2027) | 1.43B | -- | 1.35B | 1.51B | 4 |
| FQ2 2027 (Jun 2027) | 1.4B | -- | 1.32B | 1.48B | 5 |
| FQ1 2027 (Mar 2027) | 1.37B | -- | 1.29B | 1.44B | 4 |
| FQ4 2026 (Oct 2026) | 1.68B | 31.66 | 1.59B | 1.77B | 8 |
| FQ3 2026 (Jul 2026) | 1.67B | 29.75 | 1.58B | 1.76B | 5 |
| FQ2 2026 (Jun 2026) | 1.67B | 27.16 | 1.65B | 1.72B | 5 |
| FQ1 2026 (Mar 2026) | 1.66B | 22.81 | 1.64B | 1.7B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.2819 | -0.024 | -0.3059 | 1274.58% |
| FQ3 2025 (Sep 2025) | 0.23397 | -0.0951 | -0.32907 | 346.03% |
| FQ2 2025 (Jun 2025) | 0.25871 | -0.12 | -0.37871 | 315.59% |
| FQ1 2025 (Mar 2025) | 0.0026 | 0.0026 | 100% | |
| FQ4 2024 (Dec 2024) | -0.13 | -0.13 | 100% | |
| FQ3 2024 (Sep 2024) | -2.45 | -2.45 | 100% | |
| FQ2 2024 (Jun 2024) | 0.0277 | 0.0277 | 100% | |
| FQ1 2024 (Mar 2024) | 0.13 | 0.13 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $1.64B | $1.15B | $-487.75M | -42.38% |
| FQ3 2025 (Sep 2025) | $1.6B | $1.18B | $-419.73M | -35.69% |
| FQ2 2025 (Jun 2025) | $1.62B | $1.22B | $-403.03M | -33.05% |
| FQ1 2025 (Mar 2025) | $0B | $1.28B | $1280.54M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.16B | $1162.14M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.36B | $1357.22M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.35B | $1348.19M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.51B | $1510.36M | 100% |